Although not specific, its anti-MDA-MB-468 breast cancer activity, in xenograft models, seems directly related to the PARP6 inhibition, which is responsible for blocking the centrosome clustering and inducing multipolar spindle. This evidence concerns the gene PARP6 and breast cancer.